Logo do repositório
 
Publicação

Impact of the transition to HPV-based primary screening in Portugal's organized cervical cancer screening program: A controlled interrupted time-series analysis (2014-2023)

dc.contributor.authorSousa, Rita
dc.contributor.authorFonseca-Moutinho, José Alberto
dc.contributor.authorGomes, Fábio
dc.contributor.authorLoureiro, Fernanda
dc.contributor.authorGoes, Ana Rita
dc.contributor.authorSoares, Patricia
dc.date.accessioned2026-05-11T13:57:02Z
dc.date.available2026-05-11T13:57:02Z
dc.date.issued2026-04-24
dc.description.abstractObjectives: To evaluate the impact of transitioning from cytology to primary human papillomavirus (HPV) testing on cervical cancer screening (CCS) performance in Portugal's Central Region. Study design: Retrospective, population-based evaluation using a controlled interrupted time-series (CITS) approach. Methods: CCS registry data (2014–2023) were analyzed in six-month intervals. Three performance indicators (participation, test positivity, and priority referrals) were modeled using negative binomial regression with appropriate offsets. A COVID-19 covariable (national lockdown, March–June 2020) adjusted for the temporary suspension of screening services. The organized breast cancer screening (BCS) program served as an external control to distinguish CCS-specific effects from system-wide temporal fluctuations. Results: The analysis included 594,074 CCS and 888,184 BCS screening episodes. Following HPV implementation, CCS evolved differently from the control group across all outcomes. Priority referrals showed the strongest effect, with a four-fold immediate increase in CCS not observed in BCS (IRR: 4.31; 95% CI: 3.89-4.79). Participation and test positivity also diverged between programs, although with smaller magnitude changes. Post-intervention trends differed across all outcomes, although the COVID-19 pandemic, occurring shortly after implementation, complicates the interpretation of temporal patterns. Conclusions: Transition to HPV-based screening was associated with changes in screening processes, including increased identification of high-risk cases requiring priority referral while maintaining participation. By incorporating an external control, the CITS approach strengthens attribution of observed effects to HPV implementation rather than background system dynamics. These findings support HPV-based screening within organized programs and highlight its role in improving risk stratification and program performance.eng
dc.description.sponsorshipThis work was partially supported by the Foundation for Science and Technology (reference: CEECINST/00049/2021/CP2817/CT0001 and https://doi.org/10.54499/CEECINST/00049/2021/CP2817/CT0001).
dc.identifier.citationPublic Health Pract. 2026 Apr 24; 11: 100792. doi: 10.1016/j.puhip.2026.100792. 2026 Jun
dc.identifier.doi10.1016/j.puhip.2026.100792
dc.identifier.eissn2666-5352
dc.identifier.urihttp://hdl.handle.net/10400.18/11307
dc.language.isoeng
dc.peerreviewedyes
dc.publisherElsevier
dc.relation.hasversionhttps://www.sciencedirect.com/science/article/pii/S2666535226000716
dc.relation.ispartofPublic Health in Practice
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectEarly Detection of Cancer
dc.subjectUterine Cervical Neoplasms
dc.subjectMass Screening
dc.subjectHPV DNA Tests
dc.subjectInterrupted Time Series Analysis
dc.subjectHealth Policy Evaluation
dc.subjectCuidados de Saúde
dc.titleImpact of the transition to HPV-based primary screening in Portugal's organized cervical cancer screening program: A controlled interrupted time-series analysis (2014-2023)eng
dc.typejournal article
dcterms.referenceshttps://ars.els-cdn.com/content/image/1-s2.0-S2666535226000716-mmc1.docx
dspace.entity.typePublication
oaire.citation.startPage100792
oaire.citation.titlePublic Health in Practice
oaire.citation.volume11
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNameSoares
person.givenNamePatricia
person.identifier1050496
person.identifier.ciencia-id0415-632D-8609
person.identifier.orcid0000-0001-5033-9115
person.identifier.scopus-author-id52063758300
relation.isAuthorOfPublicationdf1b8bab-1e35-4561-92d0-8aeb17371a29
relation.isAuthorOfPublication.latestForDiscoverydf1b8bab-1e35-4561-92d0-8aeb17371a29

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
1-s2.0-S2666535226000716-main.pdf
Tamanho:
1.55 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
4.03 KB
Formato:
Item-specific license agreed upon to submission
Descrição: